ANTIPODES PARTNERS Ltd Q4 2025 Filing

Filed February 5, 2026

Portfolio Value

$4.8T

Holdings

127

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (127 positions)

#StockSharesValue% PortfolioType
101
VRTXVertex Pharmaceuticals Inc
127$57.0M0.00%
102
DC4Dexcom Inc
858$56.0M0.00%
103
AM6Amicus Therapeutics Inc
3,926$55.0M0.00%
104
APGEApogee Therapeutics Inc
723$54.0M0.00%
105
1GSNNovanta Inc
449$53.0M0.00%
106
GEGeneral Electric Co
141$43.0M0.00%
107
IRIngersoll Rand Inc
502$39.0M0.00%
108
NUVLNuvalent Inc
391$39.0M0.00%
109
TNGXTango Therapeutics Inc
4,513$39.0M0.00%
110
IDYAIdeaya Biosciences Inc
1,150$39.0M0.00%
111
CABACabaletta Bio Inc
17,187$37.0M0.00%
112
VRDNViridian Therapeutics Inc
1,150$35.0M0.00%
113
IRTCIRhythm Holdings Inc
189$33.0M0.00%
114
IRONDisc Medicine Inc
419$33.0M0.00%
115
SIBNSI-BONE Inc
1,470$28.0M0.00%
116
ATAIAtaiBeckley Inc
7,081$28.0M0.00%
117
MASS908 Devices Inc
5,094$26.0M0.00%
118
DAWNDay One Biopharmaceuticals Inc
2,559$23.0M0.00%
119
CERTCertara Inc
2,190$19.0M0.00%
120
ORICORIC Pharmaceuticals Inc
2,399$19.0M0.00%
121
DNTHDianthus Therapeutics Inc
459$18.0M0.00%
122
SGMTSagimet Biosciences Inc
3,176$18.0M0.00%
123
ARRYArray Technologies Inc
1,715$15.0M0.00%
124
SQMSociedad Quimica y Minera de C
182$12.0M0.00%
125
HUMAHumacyte Inc
11,648$11.0M0.00%
126
JANXJanux Therapeutics Inc
720$9.0M0.00%
127
SHLSShoals Technologies Group Inc
978$8.0M0.00%
PreviousPage 2 of 2